[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Biosimilar Insulin Sales Market Report 2017

August 2017 | 112 pages | ID: GE46C692A2EEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the global Biosimilar Insulin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Biosimilar Insulin for these regions, from 2012 to 2022 (forecast), covering
  • United States
  • China
  • Europe
  • Japan
  • Southeast Asia
  • India
Global Biosimilar Insulin market competition by top manufacturers/players, with Biosimilar Insulin sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Pfizer
  • Biogenomics
  • Eli Lilly
  • Gan&Lee Pharmaceuticals
  • Geropharm
  • Julphar Gulf Pharmaceutical Industries
  • Paras Biopharmaceuticals
  • Samsung Bioepis
  • Sedico
  • Wockhardt
  • Teva Pharmaceuticals
On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into
  • Rapid Acting Insulins
  • Short Acting Insulins
  • Intermediate Insulins
  • Long Lasting Insulins
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Biosimilar Insulin for each application, including
  • Hospital
  • Clinic
  • Medical Center
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Biosimilar Insulin Sales Market Report 2017

1 BIOSIMILAR INSULIN MARKET OVERVIEW

1.1 Product Overview and Scope of Biosimilar Insulin
1.2 Classification of Biosimilar Insulin by Product Category
  1.2.1 Global Biosimilar Insulin Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 Global Biosimilar Insulin Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Rapid Acting Insulins
  1.2.4 Short Acting Insulins
  1.2.5 Intermediate Insulins
  1.2.6 Long Lasting Insulins
1.3 Global Biosimilar Insulin Market by Application/End Users
  1.3.1 Global Biosimilar Insulin Sales (Volume) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Medical Center
1.4 Global Biosimilar Insulin Market by Region
  1.4.1 Global Biosimilar Insulin Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 United States Biosimilar Insulin Status and Prospect (2012-2022)
  1.4.3 China Biosimilar Insulin Status and Prospect (2012-2022)
  1.4.4 Europe Biosimilar Insulin Status and Prospect (2012-2022)
  1.4.5 Japan Biosimilar Insulin Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Biosimilar Insulin Status and Prospect (2012-2022)
  1.4.7 India Biosimilar Insulin Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Biosimilar Insulin (2012-2022)
  1.5.1 Global Biosimilar Insulin Sales and Growth Rate (2012-2022)
  1.5.2 Global Biosimilar Insulin Revenue and Growth Rate (2012-2022)

2 GLOBAL BIOSIMILAR INSULIN COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Biosimilar Insulin Market Competition by Players/Suppliers
  2.1.1 Global Biosimilar Insulin Sales and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Global Biosimilar Insulin Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Biosimilar Insulin (Volume and Value) by Type
  2.2.1 Global Biosimilar Insulin Sales and Market Share by Type (2012-2017)
  2.2.2 Global Biosimilar Insulin Revenue and Market Share by Type (2012-2017)
2.3 Global Biosimilar Insulin (Volume and Value) by Region
  2.3.1 Global Biosimilar Insulin Sales and Market Share by Region (2012-2017)
  2.3.2 Global Biosimilar Insulin Revenue and Market Share by Region (2012-2017)
2.4 Global Biosimilar Insulin (Volume) by Application

3 UNITED STATES BIOSIMILAR INSULIN (VOLUME, VALUE AND SALES PRICE)

3.1 United States Biosimilar Insulin Sales and Value (2012-2017)
  3.1.1 United States Biosimilar Insulin Sales and Growth Rate (2012-2017)
  3.1.2 United States Biosimilar Insulin Revenue and Growth Rate (2012-2017)
  3.1.3 United States Biosimilar Insulin Sales Price Trend (2012-2017)
3.2 United States Biosimilar Insulin Sales Volume and Market Share by Players
3.3 United States Biosimilar Insulin Sales Volume and Market Share by Type
3.4 United States Biosimilar Insulin Sales Volume and Market Share by Application

4 CHINA BIOSIMILAR INSULIN (VOLUME, VALUE AND SALES PRICE)

4.1 China Biosimilar Insulin Sales and Value (2012-2017)
  4.1.1 China Biosimilar Insulin Sales and Growth Rate (2012-2017)
  4.1.2 China Biosimilar Insulin Revenue and Growth Rate (2012-2017)
  4.1.3 China Biosimilar Insulin Sales Price Trend (2012-2017)
4.2 China Biosimilar Insulin Sales Volume and Market Share by Players
4.3 China Biosimilar Insulin Sales Volume and Market Share by Type
4.4 China Biosimilar Insulin Sales Volume and Market Share by Application

5 EUROPE BIOSIMILAR INSULIN (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Biosimilar Insulin Sales and Value (2012-2017)
  5.1.1 Europe Biosimilar Insulin Sales and Growth Rate (2012-2017)
  5.1.2 Europe Biosimilar Insulin Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Biosimilar Insulin Sales Price Trend (2012-2017)
5.2 Europe Biosimilar Insulin Sales Volume and Market Share by Players
5.3 Europe Biosimilar Insulin Sales Volume and Market Share by Type
5.4 Europe Biosimilar Insulin Sales Volume and Market Share by Application

6 JAPAN BIOSIMILAR INSULIN (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Biosimilar Insulin Sales and Value (2012-2017)
  6.1.1 Japan Biosimilar Insulin Sales and Growth Rate (2012-2017)
  6.1.2 Japan Biosimilar Insulin Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Biosimilar Insulin Sales Price Trend (2012-2017)
6.2 Japan Biosimilar Insulin Sales Volume and Market Share by Players
6.3 Japan Biosimilar Insulin Sales Volume and Market Share by Type
6.4 Japan Biosimilar Insulin Sales Volume and Market Share by Application

7 SOUTHEAST ASIA BIOSIMILAR INSULIN (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Biosimilar Insulin Sales and Value (2012-2017)
  7.1.1 Southeast Asia Biosimilar Insulin Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Biosimilar Insulin Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Biosimilar Insulin Sales Price Trend (2012-2017)
7.2 Southeast Asia Biosimilar Insulin Sales Volume and Market Share by Players
7.3 Southeast Asia Biosimilar Insulin Sales Volume and Market Share by Type
7.4 Southeast Asia Biosimilar Insulin Sales Volume and Market Share by Application

8 INDIA BIOSIMILAR INSULIN (VOLUME, VALUE AND SALES PRICE)

8.1 India Biosimilar Insulin Sales and Value (2012-2017)
  8.1.1 India Biosimilar Insulin Sales and Growth Rate (2012-2017)
  8.1.2 India Biosimilar Insulin Revenue and Growth Rate (2012-2017)
  8.1.3 India Biosimilar Insulin Sales Price Trend (2012-2017)
8.2 India Biosimilar Insulin Sales Volume and Market Share by Players
8.3 India Biosimilar Insulin Sales Volume and Market Share by Type
8.4 India Biosimilar Insulin Sales Volume and Market Share by Application

9 GLOBAL BIOSIMILAR INSULIN PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Pfizer
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Biosimilar Insulin Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Pfizer Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Biogenomics
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Biosimilar Insulin Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Biogenomics Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Eli Lilly
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Biosimilar Insulin Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Eli Lilly Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Gan&Lee Pharmaceuticals
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Biosimilar Insulin Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Gan&Lee Pharmaceuticals Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Geropharm
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Biosimilar Insulin Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Geropharm Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 Julphar Gulf Pharmaceutical Industries
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Biosimilar Insulin Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 Paras Biopharmaceuticals
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Biosimilar Insulin Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Paras Biopharmaceuticals Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 Samsung Bioepis
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Biosimilar Insulin Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Samsung Bioepis Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 Sedico
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Biosimilar Insulin Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Sedico Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 Wockhardt
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Biosimilar Insulin Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 Wockhardt Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview
9.11 Teva Pharmaceuticals

10 BIOSIMILAR INSULIN MAUFACTURING COST ANALYSIS

10.1 Biosimilar Insulin Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Biosimilar Insulin
10.3 Manufacturing Process Analysis of Biosimilar Insulin

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Biosimilar Insulin Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Biosimilar Insulin Major Manufacturers in 2016
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL BIOSIMILAR INSULIN MARKET FORECAST (2017-2022)

14.1 Global Biosimilar Insulin Sales Volume, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Biosimilar Insulin Sales Volume and Growth Rate Forecast (2017-2022)
  14.1.2 Global Biosimilar Insulin Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Biosimilar Insulin Price and Trend Forecast (2017-2022)
14.2 Global Biosimilar Insulin Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  14.2.1 Global Biosimilar Insulin Sales Volume and Growth Rate Forecast by Regions (2017-2022)
  14.2.2 Global Biosimilar Insulin Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.3 United States Biosimilar Insulin Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 China Biosimilar Insulin Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Europe Biosimilar Insulin Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 Japan Biosimilar Insulin Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.7 Southeast Asia Biosimilar Insulin Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.8 India Biosimilar Insulin Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Biosimilar Insulin Sales Volume, Revenue and Price Forecast by Type (2017-2022)
  14.3.1 Global Biosimilar Insulin Sales Forecast by Type (2017-2022)
  14.3.2 Global Biosimilar Insulin Revenue Forecast by Type (2017-2022)
  14.3.3 Global Biosimilar Insulin Price Forecast by Type (2017-2022)
14.4 Global Biosimilar Insulin Sales Volume Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Biosimilar Insulin
Figure Global Biosimilar Insulin Sales Volume Comparison (K Pcs) by Type (2012-2022)
Figure Global Biosimilar Insulin Sales Volume Market Share by Type (Product Category) in 2016
Figure Rapid Acting Insulins Product Picture
Figure Short Acting Insulins Product Picture
Figure Intermediate Insulins Product Picture
Figure Long Lasting Insulins Product Picture
Figure Global Biosimilar Insulin Sales Comparison (K Pcs) by Application (2012-2022)
Figure Global Sales Market Share of Biosimilar Insulin by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Medical Center Examples
Table Key Downstream Customer in Medical Center
Figure Global Biosimilar Insulin Market Size (Million USD) by Regions (2012-2022)
Figure United States Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Biosimilar Insulin Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Global Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Biosimilar Insulin Sales Volume (K Pcs) (2012-2017)
Table Global Biosimilar Insulin Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Global Biosimilar Insulin Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Biosimilar Insulin Sales Share by Players/Suppliers
Figure 2017 Biosimilar Insulin Sales Share by Players/Suppliers
Figure Global Biosimilar Insulin Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Biosimilar Insulin Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Biosimilar Insulin Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Biosimilar Insulin Revenue Share by Players
Table 2017 Global Biosimilar Insulin Revenue Share by Players
Table Global Biosimilar Insulin Sales (K Pcs) and Market Share by Type (2012-2017)
Table Global Biosimilar Insulin Sales Share (K Pcs) by Type (2012-2017)
Figure Sales Market Share of Biosimilar Insulin by Type (2012-2017)
Figure Global Biosimilar Insulin Sales Growth Rate by Type (2012-2017)
Table Global Biosimilar Insulin Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Biosimilar Insulin Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Biosimilar Insulin by Type (2012-2017)
Figure Global Biosimilar Insulin Revenue Growth Rate by Type (2012-2017)
Table Global Biosimilar Insulin Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Global Biosimilar Insulin Sales Share by Region (2012-2017)
Figure Sales Market Share of Biosimilar Insulin by Region (2012-2017)
Figure Global Biosimilar Insulin Sales Growth Rate by Region in 2016
Table Global Biosimilar Insulin Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Biosimilar Insulin Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Biosimilar Insulin by Region (2012-2017)
Figure Global Biosimilar Insulin Revenue Growth Rate by Region in 2016
Table Global Biosimilar Insulin Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Biosimilar Insulin Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Biosimilar Insulin by Region (2012-2017)
Figure Global Biosimilar Insulin Revenue Market Share by Region in 2016
Table Global Biosimilar Insulin Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Global Biosimilar Insulin Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Biosimilar Insulin by Application (2012-2017)
Figure Global Biosimilar Insulin Sales Market Share by Application (2012-2017)
Figure United States Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Figure United States Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Biosimilar Insulin Sales Price (USD/Pcs) Trend (2012-2017)
Table United States Biosimilar Insulin Sales Volume (K Pcs) by Players (2012-2017)
Table United States Biosimilar Insulin Sales Volume Market Share by Players (2012-2017)
Figure United States Biosimilar Insulin Sales Volume Market Share by Players in 2016
Table United States Biosimilar Insulin Sales Volume (K Pcs) by Type (2012-2017)
Table United States Biosimilar Insulin Sales Volume Market Share by Type (2012-2017)
Figure United States Biosimilar Insulin Sales Volume Market Share by Type in 2016
Table United States Biosimilar Insulin Sales Volume (K Pcs) by Application (2012-2017)
Table United States Biosimilar Insulin Sales Volume Market Share by Application (2012-2017)
Figure United States Biosimilar Insulin Sales Volume Market Share by Application in 2016
Figure China Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Biosimilar Insulin Sales Price (USD/Pcs) Trend (2012-2017)
Table China Biosimilar Insulin Sales Volume (K Pcs) by Players (2012-2017)
Table China Biosimilar Insulin Sales Volume Market Share by Players (2012-2017)
Figure China Biosimilar Insulin Sales Volume Market Share by Players in 2016
Table China Biosimilar Insulin Sales Volume (K Pcs) by Type (2012-2017)
Table China Biosimilar Insulin Sales Volume Market Share by Type (2012-2017)
Figure China Biosimilar Insulin Sales Volume Market Share by Type in 2016
Table China Biosimilar Insulin Sales Volume (K Pcs) by Application (2012-2017)
Table China Biosimilar Insulin Sales Volume Market Share by Application (2012-2017)
Figure China Biosimilar Insulin Sales Volume Market Share by Application in 2016
Figure Europe Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Biosimilar Insulin Sales Price (USD/Pcs) Trend (2012-2017)
Table Europe Biosimilar Insulin Sales Volume (K Pcs) by Players (2012-2017)
Table Europe Biosimilar Insulin Sales Volume Market Share by Players (2012-2017)
Figure Europe Biosimilar Insulin Sales Volume Market Share by Players in 2016
Table Europe Biosimilar Insulin Sales Volume (K Pcs) by Type (2012-2017)
Table Europe Biosimilar Insulin Sales Volume Market Share by Type (2012-2017)
Figure Europe Biosimilar Insulin Sales Volume Market Share by Type in 2016
Table Europe Biosimilar Insulin Sales Volume (K Pcs) by Application (2012-2017)
Table Europe Biosimilar Insulin Sales Volume Market Share by Application (2012-2017)
Figure Europe Biosimilar Insulin Sales Volume Market Share by Application in 2016
Figure Japan Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Biosimilar Insulin Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan Biosimilar Insulin Sales Volume (K Pcs) by Players (2012-2017)
Table Japan Biosimilar Insulin Sales Volume Market Share by Players (2012-2017)
Figure Japan Biosimilar Insulin Sales Volume Market Share by Players in 2016
Table Japan Biosimilar Insulin Sales Volume (K Pcs) by Type (2012-2017)
Table Japan Biosimilar Insulin Sales Volume Market Share by Type (2012-2017)
Figure Japan Biosimilar Insulin Sales Volume Market Share by Type in 2016
Table Japan Biosimilar Insulin Sales Volume (K Pcs) by Application (2012-2017)
Table Japan Biosimilar Insulin Sales Volume Market Share by Application (2012-2017)
Figure Japan Biosimilar Insulin Sales Volume Market Share by Application in 2016
Figure Southeast Asia Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Biosimilar Insulin Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia Biosimilar Insulin Sales Volume (K Pcs) by Players (2012-2017)
Table Southeast Asia Biosimilar Insulin Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Biosimilar Insulin Sales Volume Market Share by Players in 2016
Table Southeast Asia Biosimilar Insulin Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia Biosimilar Insulin Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Biosimilar Insulin Sales Volume Market Share by Type in 2016
Table Southeast Asia Biosimilar Insulin Sales Volume (K Pcs) by Application (2012-2017)
Table Southeast Asia Biosimilar Insulin Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Biosimilar Insulin Sales Volume Market Share by Application in 2016
Figure India Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Figure India Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Biosimilar Insulin Sales Price (USD/Pcs) Trend (2012-2017)
Table India Biosimilar Insulin Sales Volume (K Pcs) by Players (2012-2017)
Table India Biosimilar Insulin Sales Volume Market Share by Players (2012-2017)
Figure India Biosimilar Insulin Sales Volume Market Share by Players in 2016
Table India Biosimilar Insulin Sales Volume (K Pcs) by Type (2012-2017)
Table India Biosimilar Insulin Sales Volume Market Share by Type (2012-2017)
Figure India Biosimilar Insulin Sales Volume Market Share by Type in 2016
Table India Biosimilar Insulin Sales Volume (K Pcs) by Application (2012-2017)
Table India Biosimilar Insulin Sales Volume Market Share by Application (2012-2017)
Figure India Biosimilar Insulin Sales Volume Market Share by Application in 2016
Table Pfizer Basic Information List
Table Pfizer Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Biosimilar Insulin Sales Growth Rate (2012-2017)
Figure Pfizer Biosimilar Insulin Sales Global Market Share (2012-2017
Figure Pfizer Biosimilar Insulin Revenue Global Market Share (2012-2017)
Table Biogenomics Basic Information List
Table Biogenomics Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biogenomics Biosimilar Insulin Sales Growth Rate (2012-2017)
Figure Biogenomics Biosimilar Insulin Sales Global Market Share (2012-2017
Figure Biogenomics Biosimilar Insulin Revenue Global Market Share (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Lilly Biosimilar Insulin Sales Growth Rate (2012-2017)
Figure Eli Lilly Biosimilar Insulin Sales Global Market Share (2012-2017
Figure Eli Lilly Biosimilar Insulin Revenue Global Market Share (2012-2017)
Table Gan&Lee Pharmaceuticals Basic Information List
Table Gan&Lee Pharmaceuticals Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Gan&Lee Pharmaceuticals Biosimilar Insulin Sales Growth Rate (2012-2017)
Figure Gan&Lee Pharmaceuticals Biosimilar Insulin Sales Global Market Share (2012-2017
Figure Gan&Lee Pharmaceuticals Biosimilar Insulin Revenue Global Market Share (2012-2017)
Table Geropharm Basic Information List
Table Geropharm Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Geropharm Biosimilar Insulin Sales Growth Rate (2012-2017)
Figure Geropharm Biosimilar Insulin Sales Global Market Share (2012-2017
Figure Geropharm Biosimilar Insulin Revenue Global Market Share (2012-2017)
Table Julphar Gulf Pharmaceutical Industries Basic Information List
Table Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Sales Growth Rate (2012-2017)
Figure Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Sales Global Market Share (2012-2017
Figure Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Revenue Global Market Share (2012-2017)
Table Paras Biopharmaceuticals Basic Information List
Table Paras Biopharmaceuticals Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Paras Biopharmaceuticals Biosimilar Insulin Sales Growth Rate (2012-2017)
Figure Paras Biopharmaceuticals Biosimilar Insulin Sales Global Market Share (2012-2017
Figure Paras Biopharmaceuticals Biosimilar Insulin Revenue Global Market Share (2012-2017)
Table Samsung Bioepis Basic Information List
Table Samsung Bioepis Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Samsung Bioepis Biosimilar Insulin Sales Growth Rate (2012-2017)
Figure Samsung Bioepis Biosimilar Insulin Sales Global Market Share (2012-2017
Figure Samsung Bioepis Biosimilar Insulin Revenue Global Market Share (2012-2017)
Table Sedico Basic Information List
Table Sedico Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sedico Biosimilar Insulin Sales Growth Rate (2012-2017)
Figure Sedico Biosimilar Insulin Sales Global Market Share (2012-2017
Figure Sedico Biosimilar Insulin Revenue Global Market Share (2012-2017)
Table Wockhardt Basic Information List
Table Wockhardt Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Wockhardt Biosimilar Insulin Sales Growth Rate (2012-2017)
Figure Wockhardt Biosimilar Insulin Sales Global Market Share (2012-2017
Figure Wockhardt Biosimilar Insulin Revenue Global Market Share (2012-2017)
Table Teva Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar Insulin
Figure Manufacturing Process Analysis of Biosimilar Insulin
Figure Biosimilar Insulin Industrial Chain Analysis
Table Raw Materials Sources of Biosimilar Insulin Major Players in 2016
Table Major Buyers of Biosimilar Insulin
Table Distributors/Traders List
Figure Global Biosimilar Insulin Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Biosimilar Insulin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Biosimilar Insulin Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Global Biosimilar Insulin Sales Volume (K Pcs) Forecast by Regions (2017-2022)
Figure Global Biosimilar Insulin Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Biosimilar Insulin Sales Volume Market Share Forecast by Regions in 2022
Table Global Biosimilar Insulin Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Biosimilar Insulin Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Biosimilar Insulin Revenue Market Share Forecast by Regions in 2022
Figure United States Biosimilar Insulin Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Biosimilar Insulin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Biosimilar Insulin Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Biosimilar Insulin Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Biosimilar Insulin Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Biosimilar Insulin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Biosimilar Insulin Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Biosimilar Insulin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Biosimilar Insulin Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Biosimilar Insulin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Biosimilar Insulin Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Biosimilar Insulin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Biosimilar Insulin Sales (K Pcs) Forecast by Type (2017-2022)
Figure Global Biosimilar Insulin Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Biosimilar Insulin Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Biosimilar Insulin Revenue Market Share Forecast by Type (2017-2022)
Table Global Biosimilar Insulin Price (USD/Pcs) Forecast by Type (2017-2022)
Table Global Biosimilar Insulin Sales (K Pcs) Forecast by Application (2017-2022)
Figure Global Biosimilar Insulin Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories